OmicsBank Raises $2.25M to Expand Clinical Data Infrastructure Globally for Healthcare, Life Sciences, and Frontier AI Labs

OmicsBank said seed funding from Redesign Health will fuel its U.S. expansion and broaden access to clinical and multi-omics data sourced from Asia, supporting greater diversity in drug development and healthcare AI. The news is positive for the company’s growth and data footprint, though no funding amount or financial performance figures were provided, limiting near-term market impact.